10XIt sounds like you are long-holding investor who has been incredibly patient yet has time-sensitivity needs relating to your SVA position. I get it.
I share some of your frustrations, yet, to be honest, the Biotechs I have done well in have always taken more time to monetize. I am not sure what your ACB is, but assuming it was around 2+ years ago when you started to build a position, you are likely already up 10x. Very few other sectors would have compared to this uptick. I also have discovered, through other investments I have made in the biotech sector, the longer a deal takes to paper, likely will have accretive benefits to the long holding investor. Management is versed in deal-making, licencing, legal and an external NY group is working on this too. Keep in mind this is a relatively newly-minted space (regen med), and science, rights of use, M&A implications, all of this this often takes more time to hammer out. I do share some of your fatigue. But I sense this will all be worth it. At this stage, I know ‘quiet is good’. Thank you for your post. I am adding at these levels, but like you, are eager to see all of this cross the line.